​

Neurogene Ownership | Who Owns Neurogene?

OverviewForecastRevenueFinancialsChart

Neurogene Ownership Summary

Neurogene is owned by 94.90% institutional investors, 10.69% insiders.

NGNE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNeurogene94.90%10.69%-5.60%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024928.24%16,089,35716.19%941.42%5831.82%17-22.73%
Sep 30, 20248528.79%13,847,6594.39%811.33%444.76%2257.14%
Jun 30, 20246610.00%13,265,5279.37%781.52%42-2.33%1455.56%
Mar 31, 20246076.47%12,129,50233.19%711.42%4326.47%9-
Dec 31, 202334-9,107,140-71-34---

Recent Insider Transactions

DateNameRoleActivityValue
Mar 13, 2025Cvijic Christine Mikail President and CFOSell$76.25K
Nov 26, 2024Samsara BioCapital GP, LLC-Buy$55.00K
Nov 26, 2024Samsara BioCapital GP, LLC-Buy$406.80K
Nov 26, 2024Samsara BioCapital GP, LLC-Buy$280.99K
Nov 26, 2024Samsara BioCapital GP, LLC-Buy$516.83K

Insider Transactions Trends

DateBuySell
2024 Q46-
2024 Q2--
2024 Q1--
2023 Q4--

NGNE Ownership FAQ

Who Owns Neurogene?

Neurogene shareholders are primarily institutional investors at 94.90%, followed by 10.69% insiders and -5.59% retail investors. The average institutional ownership in Neurogene's industry, Biotech Stocks , is 68.48%, which Neurogene exceeds.

Does Blackrock own Neurogene?

BlackRock is not among the top 10 institutional shareholders of Neurogene.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools